Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (9): 817-821.doi: 10.12372/jcp.2024.23e1132
• Literature Review • Previous Articles Next Articles
Reviewer: TANG Chuanyi, Reviser: YAO Zhirong
Received:
2023-11-28
Online:
2024-09-15
Published:
2024-09-04
TANG Chuanyi, YAO Zhirong. The role of early regular use of emollients in the prevention and treatment of infantile atopic dermatitis[J].Journal of Clinical Pediatrics, 2024, 42(9): 817-821.
[1] | 中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2020版)[J]. 中华皮肤科杂志, 2020, 53(2): 81-88. |
[2] | 顾恒, 尤立平, 刘永生, 等. 我国10城市学龄前儿童特应性皮炎现况调查[J]. 中华皮肤科杂志, 2004, 37(1): 29-31. |
[3] | Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1-7ys[J]. Sci Rep, 2016, 6: 29751. |
[4] |
Guo Y, Zhang H, Liu Q, et al. Phenotypic analysis of atopic dermatitis in children aged 1-12 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence[J]. J Eur Acad Dermatol Venereol. 2019, 33(8): 1569-1576.
doi: 10.1111/jdv.15618 pmid: 30989708 |
[5] | Gonzalez-U, Vidaurri C, Gomez-Nuñez A, et al. Comorbidities & burden of disease in atopic dermatitis[J]. Asian Pac J Allergy Immunol, 2023, 41(2): 97-105. |
[6] |
Domínguez O, Plaza AM, Alvaro M. Relationship between atopic dermatitis and food allergy[J]. Curr Pediatr Rev, 2020, 16(2): 115-122.
doi: 10.2174/1573396315666191111122436 pmid: 31713486 |
[7] |
Yang L, Fu J, Zhou Y. Research progress in atopic march[J]. Front Immunol, 2020, 11: 1907.
doi: 10.3389/fimmu.2020.01907 pmid: 32973790 |
[8] |
Luger T, Amagai M, Dreno B, et al. Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents[J]. J Dermatol Sci, 2021, 102(3): 142-157.
doi: 10.1016/j.jdermsci.2021.04.007 pmid: 34116898 |
[9] |
Kim Y, Lim KM. Skin barrier dysfunction and filaggrin[J]. Arch Pharm Res, 2021, 44(1): 36-48.
doi: 10.1007/s12272-021-01305-x pmid: 33462753 |
[10] |
Bataille V, Lens M, Spector TD. The use of the twin model to investigate the genetics and epigenetics of skin diseases with genomic, transcriptomic and methylation data[J]. J Eur Acad Dermatol Venereol, 2012, 26(9): 1067-1073.
doi: 10.1111/j.1468-3083.2011.04444.x pmid: 22243446 |
[11] | Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms[J]. Allergy Clin Immunol, 2008, 121(6): 1337-1343. |
[12] | Moosbrugger V, Leprince C, Méchin MC, et al. Revisiting the roles of filaggrin in atopic dermatitis[J]. Int J Mol Sci, 2022, 23(10): 5318. |
[13] | Yang G, Seok JK, Kang HC, et al. Skin barrier abnormalities and immune dysfunction in atopic dermatitis[J]. Int J Mol Sci, 2020, 21(8): 2867. |
[14] | Edslev SM, Agner T, Andersen PS. Skin microbiome in atopic dermatitis[J]. Acta Derm Venereol, 2020, 100(12): adv00164. |
[15] | Baker P, Huang C, Radi R, et al. Skin barrier function: the interplay of physical, chemical, and immunologic properties[J]. Cells, 2023, 12(23): 2745. |
[16] | Tsuge M, Ikeda M, Matsumoto N, et al. Current insights into atopic march[J]. Children (Basel), 2021, 8(11): 1067. |
[17] |
Lack G. Epidemiologic risks for food allergy[J]. J Allergy Clin Immunol, 2008, 121(6): 1331-1336.
doi: 10.1016/j.jaci.2008.04.032 pmid: 18539191 |
[18] | Dębińska A, Sozańska B. Epicutaneous sensitization and food allergy: preventive strategies targeting skin barrier repair-facts and challenges[J]. Nutrients, 2023, 15(5): 1070. |
[19] | Allenova A, Darlenski R. The hen and the egg question in atopic dermatitis: allergy or eczema comes first[J]. Asthma Res Pract, 2023, 9(1): 1. |
[20] | Ramírez-Marín HA, Singh AM, Ong PY, et al. Food allergy testing in atopic dermatitis[J]. JAAD Int, 2022, 9: 50-56. |
[21] | Giannetti A, Cipriani F, Indio V, et al. Influence of atopic dermatitis on cow's milk allergy in children[J]. Medicina (Kaunas), 2019, 55(8): 460. |
[22] |
Yang L, Fu J, Zhou Y. Research progress in atopic march[J]. Front Immunol, 2020, 11: 1907.
doi: 10.3389/fimmu.2020.01907 pmid: 32973790 |
[23] |
Langan S, Irvine A, Weidinger S. Atopic dermatitis[J]. Lancet, 2020, 396(10247): 345-360.
doi: S0140-6736(20)31286-1 pmid: 32738956 |
[24] |
Yuhouvon Kobyletzki LB, Bornehag CG, Hasselgren M, et al. Eczema in early childhood is strongly associated with thedevelopment of asthma and rhinitis in a prospective cohort[J]. BMC Dermatol, 2012, 12: 11.
doi: 10.1186/1471-5945-12-11 pmid: 22839963 |
[25] |
Matsumoto K, Iikura K, Morita H, et al. Barrier dysfunction in the atopic march-how does atopic dermatitis lead to asthma in children?[J]. J Allergy Clin Immunol, 2020, 145(6): 1551-1553.
doi: S0091-6749(20)30558-3 pmid: 32344057 |
[26] | Umar BU, Rahman S, Dutta S, et al. Management of atopic dermatitis: the role of Tacrolimus[J]. Cureus, 2022, 14(8): e28130. |
[27] | Fu H, Li Y, Huang H, et al. Serum vitamin D level and efficacy of vitamin D supplementation in children with atopic dermatitis: a systematic review and meta-analysis[J]. Comput Math Methods Med, 2022, 2022: 9407888. |
[28] |
Miyaji Y, Yang L, Yamamoto-Hanada K, et al. Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age[J]. J Allergy Clin Immunol Pract, 2020, 8(5):1721-1724.
doi: S2213-2198(19)31018-9 pmid: 31821918 |
[29] | Uwe, Matterne, Merle, et al. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema[J]. Cochrane Database Syst Rev, 2019, 1(1): CD012167. |
[30] |
Miyaji Y, Yang L, Yamamoto-Hanada K, et al. Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age[J]. J Allergy Clin Immunol Pract, 2020, 8(5): 1721-1724.
doi: S2213-2198(19)31018-9 pmid: 31821918 |
[31] | Uwe, Matterne, Merle, et al. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema[J]. Cochrane Database Syst Rev, 2019, 1(1): CD012167. |
[32] | Williams HC, Chalmers J. Prevention of atopic dermatitis[J]. Acta Derm Venereol, 2020, 100(12): adv00166. |
[33] | Rajkumar J, Chandan N, Lio P, et al. The skin barrier and moisturization: function, disruption, and mechanisms of repair[J]. Skin Pharmacol Physiol, 2023, 36(4): 174-185. |
[34] |
Gupta J, Grube E, Ericksen MB, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity[J]. J Allergy Clin Immunol, 2008, 121(3): 725-730.
doi: 10.1016/j.jaci.2007.12.1161 pmid: 18249438 |
[35] |
Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies[J]. J Am Acad Dermatol, 2023, 89(1): e1-e20.
doi: 10.1016/j.jaad.2022.12.029 pmid: 36641009 |
[36] |
Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations[J]. J Eur Acad Dermatol Venereol, 2022, 36(11): 1904-1926.
doi: 10.1111/jdv.18429 pmid: 36056736 |
[37] | Saeki H, Ohya Y, Furuta J, et al. English version of clinical practice guidelines for the management of atopic dermatitis 2021[J]. J Dermatol, 2022, 49(10):e315-e375. |
[38] |
Gupta S, Ramam M, Sharma VK, et al. Evaluation of a paraffin-based moisturizer compared to a ceramide-based moisturizer in children with atopic dermatitis: a double-blind, randomized controlled trial[J]. Pediatr Dermatol, 2023, 40(4):627-632.
doi: 10.1111/pde.15355 pmid: 37269189 |
[39] | Piquero-Casals J, Morgado-Carrasco D, Granger C, et al. Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties[J]. Dermatol Ther (Heidelb), 2021, 11(6): 1905-1915. |
[40] | Dębińska A. New treatments for atopic dermatitis targeting skin barrier repair via the regulation of FLG expression[J]. J Clin Med, 2021, 10(11): 2506. |
[41] |
Danby SG, Andrew PV, Taylor RN, et al. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis[J]. Clin Exp Dermatol, 2022, 47(6): 1154-1164.
doi: 10.1111/ced.15141 pmid: 35167133 |
[42] | Lun HK, Charmaine KJS, Gigi NWG, et al. Emollient treatment of atopic dermatitis: latest evidence and clinical considerations[J]. Drugs Context, 2018, 7: 212530. |
[43] | Lowe A, Su J, Allen K, et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study[J]. Br J Dermatol, 2018, 178(1): e19-e21. |
[44] | Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention[J]. J Allergy Clin Immunol, 2014, 34(4): 818-823. |
[45] |
Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis[J]. J Allergy Clin Immunol, 2014, 134(4): 824-830.
doi: 10.1016/j.jaci.2014.07.060 pmid: 25282564 |
[46] | Lowe A, Su J, Tang M, et al. PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy[J]. BMJ Open, 2019, 9(3): e024594. |
[47] |
Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial[J]. Lancet, 2020, 395(10228): 951-961.
doi: S0140-6736(19)32983-6 pmid: 32087121 |
[48] |
Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial[J]. Lancet, 2020, 395(10228): 962-972.
doi: S0140-6736(19)32984-8 pmid: 32087126 |
|